Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlucoTab with ultra-long acting insulin analogue in non-critically ill type 2 diabetes inpatients
DRKS00015119Phase 4Completed
- Sponsor
- Medical University of Graz, Department of Endocrinology and Metabolism
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin degludec and insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Graz, Department of Endocrinology and Metabolism. Started Apr 2019; status: completed.
02
Drugs
insulin degludecinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on DRKS00015119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00015119.